SLC28A1 and familial pancreatic carcinoma: hCNT1 is frequently diminished in pancreatic cancer cells compared with normal pancreatic ductal epithelial cells[26], so drug inhibition or degradation of hCNT1 can increase the transportation of gemcitabine, and thus improve its efficacy[27].